Skip to content
10-Q

Quarterly Report

ACADIA PHARMACEUTICALS INC ACAD

0001193125-25-267453

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 29, 2025 169.18M sh
Shares Diluted Q3 2025 · Sep 30, 2025 170.65M sh
Shares Diluted Q3 2025 · Sep 30, 2025 169.16M sh
Shares Diluted Q3 2025 · Sep 30, 2024 166.18M sh
Shares Diluted Q3 2025 · Sep 30, 2024 166.14M sh
Capex Q3 2025 · Sep 30, 2025 $685K
Capex Q3 2025 · Sep 30, 2024 $70K
Operating Cash Flow Q3 2025 · Sep 30, 2025 $158.57M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $117.34M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $258M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $319.59M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $155.15M
Cash And Equivalents Q3 2025 · Dec 31, 2023 $188.66M
Stockholders Equity Q3 2025 · Sep 30, 2025 $917.27M
Stockholders Equity Q3 2025 · Jun 30, 2025 $822.38M
Stockholders Equity Q3 2025 · Dec 31, 2024 $732.79M
Stockholders Equity Q3 2025 · Sep 30, 2024 $577.18M
Stockholders Equity Q3 2025 · Jun 30, 2024 $516.7M
Stockholders Equity Q3 2025 · Dec 31, 2023 $431.76M
Current Liabilities Q3 2025 · Sep 30, 2025 $356.58M
Current Liabilities Q3 2025 · Dec 31, 2024 $394.87M
Total Liabilities Q3 2025 · Sep 30, 2025 $413.5M
Total Liabilities Q3 2025 · Dec 31, 2024 $454.96M
Current Assets Q3 2025 · Sep 30, 2025 $1.08B
Current Assets Q3 2025 · Dec 31, 2024 $938.32M
Total Assets Q3 2025 · Sep 30, 2025 $1.33B
Total Assets Q3 2025 · Dec 31, 2024 $1.19B
Eps Diluted Q3 2025 · Sep 30, 2025 $0.42
Eps Diluted Q3 2025 · Sep 30, 2025 $0.69
Eps Diluted Q3 2025 · Sep 30, 2024 $0.20
Eps Diluted Q3 2025 · Sep 30, 2024 $0.50
Eps Basic Q3 2025 · Sep 30, 2025 $0.43
Eps Basic Q3 2025 · Sep 30, 2025 $0.70
Eps Basic Q3 2025 · Sep 30, 2024 $0.20
Eps Basic Q3 2025 · Sep 30, 2024 $0.50
Sga Expense Q3 2025 · Sep 30, 2025 $133.4M
Sga Expense Q3 2025 · Sep 30, 2025 $393.28M
Sga Expense Q3 2025 · Sep 30, 2024 $133.29M
Sga Expense Q3 2025 · Sep 30, 2024 $358.35M
Rd Expense Q3 2025 · Sep 30, 2025 $87.83M
Rd Expense Q3 2025 · Sep 30, 2025 $244.05M
Rd Expense Q3 2025 · Sep 30, 2024 $66.61M
Rd Expense Q3 2025 · Sep 30, 2024 $202.52M
Net Income Q3 2025 · Sep 30, 2025 $71.78M
Net Income Q3 2025 · Sep 30, 2025 $117.43M
Net Income Q3 2025 · Sep 30, 2024 $32.77M
Net Income Q3 2025 · Sep 30, 2024 $82.71M
Operating Income Q3 2025 · Sep 30, 2025 $35.76M
Operating Income Q3 2025 · Sep 30, 2025 $87.42M
Operating Income Q3 2025 · Sep 30, 2024 $31.64M
Operating Income Q3 2025 · Sep 30, 2024 $77.29M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $21.65M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $62.77M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $18.86M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $60.04M
Revenue Q3 2025 · Sep 30, 2025 $278.63M
Revenue Q3 2025 · Sep 30, 2025 $787.52M
Revenue Q3 2025 · Sep 30, 2024 $250.4M
Revenue Q3 2025 · Sep 30, 2024 $698.2M